This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
Postpartum, Lactation, Drugs in Breast Milk, Mammary Drug Transporters, BCRP, OCT1
This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
Drug Excretion in Breast Milk
-
University of Washington, Seattle, Washington, United States, 98195
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
14 Days to 50 Years
ALL
Yes
University of Washington,
Mary Hebert, PharmD, FCCP, PRINCIPAL_INVESTIGATOR, University of Washington
2028-09-30